<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <title>reveal.js - The HTML Presentation Framework</title>
  <meta name="description" content="A framework for easily creating beautiful presentations using HTML">
  <meta name="author" content="Hakim El Hattab">
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">
  <link rel="stylesheet" href="https://fn.sec4share.me/Victoza/yRoom/reveal/reveal/dist/reveal.css">
  <link rel="stylesheet" href="https://fn.sec4share.me/Victoza/yRoom/reveal/reveal/dist/theme/white-segoe.css" id="theme">
  <link href="http://fonts.cdnfonts.com/css/segoe-ui-4" rel="stylesheet">

  
  <!-- For syntax highlighting -->
  <!--link rel="stylesheet" href="lib/css/zenburn.css"-->

  <!-- If the query includes 'print-pdf', include the PDF print sheet -->
  <script>
    if (window.location.search.match(/print-pdf/gi)) {
      var link = document.createElement('link');

      link.rel = 'stylesheet';
      link.type = 'text/css';
      link.href = 'css/print/pdf.css';
      document.getElementsByTagName('head')[0].appendChild(link);
    }
  </script>

  <!--[if lt IE 9]>
    <script src="lib/js/html5shiv.js"></script>
  <![endif]-->
  <style>
    ul {
      list-style: none;
    }
    
    ul li::before {
      content: "\2022";
      color:#7d9ad0;
      display: inline-block; 
      margin-left: -1em;
      width: 1em;
    }
    </style>
</head>
<body>
    <div class="reveal">
        <div class="slides">
             <section data-background-color="#092f5e" >       
                 <div style="width: 50%;text-align: center;display: block;
                 margin-left: auto;margin-right: auto;">
                   <img src="https://fn.sec4share.me/NovoMix/203/Slide_deck/01_01.png"/>
                 </div>
             </section>
            <section>
              <div style=" border-top:5px solid #9d9488;border-bottom: 5px solid #9d9488; display: inline-block;">    
                <div style="width: 100%; float: left; text-align: left; direction: ltr;">
                  <p style="color: #092f5e; font-size: 20pt;">
                   <b>Hospitalisation alone accounts for ~55% <br>of direct medical costs for type 2 diabetes<sup>1</sup></b>
                  </p>   
                </div>
                <div style="width: 55%; float: left;">
                    <img src="https://fn.sec4share.me/NovoMix/203/Slide_deck/02_01.png"/>
                </div>
                <div style="direction: ltr; float: left;text-align: left; width: 45%;margin-top: 130px;">
                    <p style=" font-size: 13pt;color: #9d9488;"><b>Distribution of overall costs for people <br> with type 2 diabetes<sup style="font-size: 8pt;">1</sup></b></p>
                </div>
                <div style="margin-top: 150px;float: left;text-align: left;">
                    <p style="color: #7d9ad0;font-size: 10pt;">
                       <b>Adapted from Petersen MP. et al. 2018.<sup style="font-size: 10px;">1</sup></b>
                    </p>
                    <p style="color:#9d9488; font-size: 10pt;margin-top: -15px;">
                        Due to rounding, numbers may not add up to 100%. 
                    </p>
                </div>
              </div>  
            </section>
            <section>
                <div style="display: inline-block;">
                    <div style=" color:#092f5e ; font-size: 19pt;text-align: left;width: 90%;margin-left: 3%;">
                        <p>
                            PEN USE OFFERS IMPROVED HEALTH ECONOMIC<br> BENEFITS VS VIAL AND SYRINGE <sup style="font-size: 9pt;">2,3,4,5,6</sup>
                        </p>
                    </div>
                    <div style="width: 50%; float: left;">
                        <img width="90%" src="https://fn.sec4share.me/NovoMix/203/Slide_deck/03_01.png">
                    </div>
                    <div style="width: 50%; float: left;">
                        <img width="90%" src="https://fn.sec4share.me/NovoMix/203/Slide_deck/03_02.png">
                    </div>
                </div>
            </section>
            <section>
                <div>
                    <div>
                        <h6 style="color: #092f5e" > Hypoglycaemia</h6>
                    </div>
                    <div>
                        <div style="color: #092f5e;">
                            <p style=" width: 100%;text-align: center;font-size: 16pt;">Hypoglycaemic episodes can be a considerable problem with BHI<sup style="font-size: 9pt;">8,9</sup></p>
                        </div>
                    </div>
                    <div style="display: inline-block;">
                        <div style="float: left; width: 48%;font-size: 14pt;color: #092f5e;text-align: center;">
                             <p><b>Major hypoglycaemia</b></p>
                        </div>
                        <div style="float: left; width: 52%;font-size: 14pt;color: #092f5e;text-align: center;">
                            <p><b>Nocturnal hypoglycaemia</b></p>
                        </div>
                        <div style="width: 10%;float: left;text-align: left;margin-left: 12%;">
                            <img src="https://fn.sec4share.me/NovoMix/203/Slide_deck/04_01.png"/>
                        </div>
                        <div style="width: 40%;float: left;font-size: 50pt;text-align: left;">
                             <b><p style="color: #092f5e;">55%</p></b>
                        </div>
                        <div style="width: 10%;float: left;text-align: left;">
                            <img src="https://fn.sec4share.me/NovoMix/203/Slide_deck/04_02.png"/>
                        </div>
                        <div style="width: 28%;float: left;font-size: 50pt;text-align: left;">
                            <b><p style="color: #092f5e;">50%</p></b>
                        </div>
                        <div style="color: #092f5e ;width: 47%;float: left;text-align: left;margin-left: 13%;">
                            <p style="font-size: 12pt;"><b>REDUCTION</b> in the likelihood <br> of<b> major hypoglycaemic</b><br>events vs BHI <sup style="font-size: 8pt;">9</sup></p>
                        </div>
                        <div style="color: #092f5e ;width: 40%;float: left;text-align: left;">
                           <p style="font-size: 12pt;"><b>REDUCTION</b> in the likelihood <br> of<b> nocturnal hypoglycaemic </b><br>events vs BHI <sup style="font-size: 8pt;">9</sup></p>
                        </div>
                    </div>
                
                    <div style="height: 20%;">
                        <div  style=" background-size: 100% 100%; background-color: no-repeat; background-image: url('https://fn.sec4share.me/NovoMix/203/Slide_deck/04_03.png'); background-repeat: no-repeat; ">
                            <p style="color: white; font-size: 18pt; padding: 3% 0% 5% 0%">NOVOMIX<sup>®</sup> 30 reduces the risk of hypoglycaemia events vs BHI<sup>9-12</sup></p>
                        </div>
                    </div>
                </div>
             
         </section>
         <section>
             <div>
                 <div style="text-align: center;"><h5 style="color: #092f5e ;">Mealtime flexibility</h5></div>
                 <div>
                     <div style="float:left ;width: 45%; text-align: left;margin-top: 5%">
                        <img width="80%" src="https://fn.sec4share.me/NovoMix/203/Slide_deck/05_01.png">
                     </div>
                     <div style="float: left;text-align: left;width: 55%;color:#092f5e ;margin-top: 8%;">
                         <b><p style="font-size: 20pt;">NOVOMIX<span style="vertical-align:0.5em; font-size:0.7em;">&reg;</span>30 allows flexible injection timing <sup style="font-size: 10pt;">8-13</sup></p></b>
                         <ul style="font-size: 17pt;">
                             <li>
                                BHI needs to be administrated at least 30 minutes before a meal<sup style="font-size: 10pt;">8</sup>
                             </li>
                             <li>
                                Adherence to BHI injection timing is poor<sup style="font-size: 10pt;">8</sup>
                             </li>
                             <li>
                                NOVOMIX<span style="vertical-align:0.5em; font-size:0.6em;">&reg;</span> 30 can be taken just before or immediately after a meal8 <sup style="font-size: 10pt;">8-13</sup>
                             </li>
                         </ul>
                     </div>
                 </div>
             </div>
         </section>
         <section>
             <div style="display: inline-block;color: #092f5e;font-size: 20pt;">
                 <div style="text-align: left;">
                     <p>It’s easy to upgrade your patients to NovoMix<span style="vertical-align:0.5em; font-size:0.7em;">&reg;</span>30 from BHI by using a simple 1:1 conversion.<sup style="font-size: 10pt;">13</sup>
                        Start NovoMix<span style="vertical-align:0.5em; font-size:0.7em;">&reg;</span> 30 with the same total daily insulin dose as their BHI regimen.<sup style="font-size: 10pt;">*13</sup>
                    </p>
                 </div>
                 <div>
                     <img width="70%" src="https://fn.sec4share.me/NovoMix/203/Slide_deck/06_01.png">
                 </div>
                 <div>
                     <p>
                        The dose can be administered up to <b>three times daily</b>.<sup style="font-size: 10pt;">14,15</sup>
                     </p>

                 </div>
             </div>
         </section>
         <section>
             <div>
             <div style="background-color: #092f5e;text-align: left;padding: 2% 0% 2% 5%;">
                <p style="color: white;font-size: 40pt;">NovoMix<span style="vertical-align:0.5em; font-size:0.7em;">&reg;</span>30 vs. BHI:</p>
                    <p style=" color:white; font-size: 30pt;margin-top: -2%;">Advantages of analogue pens vs<br>vials & safety and efficacy vs Biphasic<br>Human insulins</p>
             </div>
             <div>
                 <p style="text-align: left;color: #7d9ad0;font-size: 10pt;margin-left: 12%;">References</p>
             </div>
             <ol style="margin-left: 9%; font-size: 8pt;">
                 <li>Petersen MP et al. Diabetes Care 2018;41:917–928.</li>
                 <li>Xie L,et al. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis. Diabetes Technol Ther. 2014;16(9):567–75.</li>
                 <li>Corsi A, et al. Pre-fi lled insulin pen in newly insulin-treated diabetic patients over 60 years old. Diabetes Nutr Metab. 1997;10(2):78–81.</li>
                 <li>Grabner M, et al. Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial. Postgrad Med. 2013;125(3):204–213.</li>
                 <li> Miao R, et al. Does device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes. Diabetes Sci Technol. 2014;8(1):150–158.</li>
                 <li>Lee W, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther. 2006;28:1712–1725.</li>
                 <li>Asakura T, et al. A Comparison of the Handling and Accuracy of Syringe and Vial Versus Prefi lled Insulin Pen (FlexPen<sup>®</sup>). Diabetes Technol Ther. 2009;11(10):657–661</li>
                 <li>Garber AJ et al. Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab 2007;9(5):630–63.</li>
                 <li>Davidson JA et al. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. Clin Ther 2009;31(8): 1641–165.</li>
                 <li>Shah S et al. Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix<sup>®</sup> 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study. Int J Clin Pract 2009;63(4):574–582.</li>
                 <li>El Naggar NK et al. Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: results from the A1chieve study. Diabetes Res Clin Pract 2012;98(3):408–41.</li>
                 <li>Shestakova M et al. Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study. Curr Med Res Opin 2007;23(12):3209–321.</li>
                 <li> NovoMix®30 Locally approved Labeling in Iran (STF-Dec-2019).</li>
                 <li>Unnikrishnan A et al. Int J Clin Pract 2009;63:1571–1577.</li>
                 <li> Khamseh M et al. ADA 2012; Poster 1074–P.</li>
             </ol>
             </div>
         </section>
       
        </div>
      
    </div>
    
  <!-- Slides  content to be added here -->

  <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js"></script>
  <!--script src="lib/js/head.min.js"></script-->
  <script src="https://fn.sec4share.me/Victoza/yRoom/reveal/reveal/dist/reveal.js"></script>
  <script src="https://dummy.dev.yroom.app/yRoomRevealExtensions.js"></script>
  <script>
    // Full list of configuration options available here:
    // https://github.com/hakimel/reveal.js#configuration
    Reveal.initialize({
      controls: true,
      progress: true,
      history: true,
      center: true,
      postMessageEvents: true,
      postMessage: true,

      //theme: Reveal.getQueryHash().theme, // available themes are in /css/theme
      //transition: Reveal.getQueryHash().transition || 'default', // default/cube/page/concave/zoom/linear/fade/none

      // Parallax scrolling
      // parallaxBackgroundImage: 'https://s3.amazonaws.com/hakim-static/reveal-js/reveal-parallax-1.jpg',
      // parallaxBackgroundSize: '2100px 900px',

      // Optional libraries used to extend on reveal.js
      dependencies: [{
      /*  src: 'lib/js/classList.js',
        condition: function () {
          return !document.body.classList;
        }
      }, {*/
        src: 'https://fn.sec4share.me/Victoza/yRoom/reveal/revealplugin/markdown/marked.js',
        condition: function () {
          return !!document.querySelector('[data-markdown]');
        }
      }, {
        src: 'https://fn.sec4share.me/Victoza/yRoom/reveal/reveal/plugin/markdown/markdown.js',
        condition: function () {
          return !!document.querySelector('[data-markdown]');
        }
      }, {
        src: 'https://fn.sec4share.me/Victoza/yRoom/reveal/reveal/plugin/highlight/highlight.js',
        async: true,
        callback: function () {
          hljs.initHighlightingOnLoad();
        }
      }, {
        src: 'https://fn.sec4share.me/Victoza/yRoom/reveal/reveal/plugin/zoom-js/zoom.js',
        async: true,
        condition: function () {
          return !!document.body.classList;
        }
      }, {
        src: 'https://fn.sec4share.me/Victoza/yRoom/reveal/reveal/plugin/notes/notes.js',
        async: true,
        condition: function () {
          return !!document.body.classList;
        }
      }]
    });
  </script>
</body>
</html>